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Carbonic anhydrase (CA) (carbonate hydrolyase, EC
4.2.1.1) is a ubiquitous zinc-containing enzyme that cat+
alyzes the reversible hydration of CO2 to HCO3 and H .
This enzyme, which participates in crucial physiological
processes, is present in most tissues including erythrocytes (1).

tionally, the effects of rainbow trout (Oncorhynchus
mykiss) low molecular weight plasma inhibitors on CA
enzyme activities in human CA-II in vitro and rat erythrocyte in vivo were investigated, and it was determined
that rainbow trout plasma inhibitors had an inhibitory
effect in in vitro and in vivo experiments (5).

To date 14 different CA isozymes have been described
in higher vertebrates. These include cytosolic, membranebound, mitochondrial and secretory forms and several
acatalytic forms (2).

It is known that many CA inhibitors used clinically are
synthesized in the laboratory and so they are not natural
inhibitors and may have undesired effects for living
metabolism. According to recent findings, natural plasma
inhibitors may be used clinically in the treatment of some
of the diseases indicated above. However, further
research is necessary to purify these inhibitors from the
plasma and determine their precise chemical nature. After
that, the dosage, duration and methods of administration
of these inhibitors should also be investigated.

CA inhibitors, especially aromatic and heterocyclic sulfonamides, have been used clinically for more than 45
years in the treatment of a variety of diseases such as
glaucoma, epilepsy, congestive heart failure, mountain
sickness, gastric and duodenal ulcers, osteoporosis and
acid-base disequilibria. It has also been reported that
acetazolamide might also function as a modulator of anticancer therapies in combination with different cytotoxic
agents (3).
Henry et al. (4) measured the presence of inhibitors in
plasma and subcellular fractions of gill tissue in elasmobranches and teleosts. They reported that plasma CA
inhibitors were highly species-specific in salmonids. Addi-
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